Article Text

Download PDFPDF
Assessment of socioeconomic and racial differences in patients undergoing concurrent gynecologic oncology and urogynecology surgeries: a National Inpatient Sample (NIS) database study
  1. Ioana Marcu1,
  2. Eric M McLaughlin2,
  3. Silpa Nekkanti1,
  4. Wafa Khadraoui3,
  5. Julia Chalif3,
  6. Jessica Fulton4,
  7. David O’Malley3 and
  8. Laura M Chambers3
    1. 1 Urogynecology, The Ohio State University Department of Obstetrics and Gynecology, Columbus, Ohio, USA
    2. 2 Biostatistics, The Ohio State University, Columbus, Ohio, USA
    3. 3 Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, Ohio, USA
    4. 4 The Ohio State University College of Medicine, Columbus, Ohio, USA
    1. Correspondence to Dr Laura M Chambers, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center Arthur G James Cancer Hospital and Richard J Solove Research Institute, Columbus, OH 43210, USA; laura.chambers{at}osumc.edu

    Abstract

    Objective To assess social determinants of health impacting patients undergoing gynecologic oncology versus combined gynecologic oncology and urogynecology surgeries.

    Methods We identified patients who underwent gynecologic oncology surgeries from 2016 to 2019 in the National Inpatient Sample using the International Classification of Diseases-10 codes. Demographics, including race and insurance status, were compared for patients who underwent gynecologic oncology procedures only (Oncologic) and those who underwent concurrent incontinence or pelvic organ prolapse procedures (Urogynecologic-Oncologic). A logistic regression model assessed variables of interest after adjustment for other relevant variables.

    Results From 2016 to 2019 the National Inpatient Sample database contained 389 (1.14%) Urogynecologic-Oncologic cases and 33 796 (98.9%) Oncologic cases. Urogynecologic-Oncologic patients were less likely to be white (62.1% vs 68.8%, p=0.02) and were older (median 67 vs 62 years, p<0.001) than Oncologic patients. The Urogynecologic-Oncologic cohort was less likely to have private insurance as their primary insurance (31.9% vs 38.9%, p=0.01) and was more likely to have Medicare (52.2% vs 42.8%, p=0.01). After multivariable analysis, black (adjusted odds ratio (aOR) 1.41, 95% CI 1.05 to 1.89, p=0.02) and Hispanic patients (aOR 1.53, 95% CI 1.11 to 2.10, p=0.02) remained more likely to undergo Urogynecologic-Oncologic surgeries but the primary expected payer no longer differed significantly between the two groups (p=0.95). Age at admission, patient residence, and teaching location remained significantly different between the groups.

    Conclusions In this analysis of a large inpatient database we identified notable racial and geographical differences between the cohorts of patients who underwent Urogynecologic-Oncologic and Oncologic procedures.

    • Gynecologic Surgical Procedures
    • Gynecology
    • Surgical Oncology
    • Surgical Procedures, Operative

    Data availability statement

    All data relevant to the study are included in the article or uploaded as supplementary information.

    Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Data availability statement

    All data relevant to the study are included in the article or uploaded as supplementary information.

    View Full Text

    Footnotes

    • X @laurajmoulton

    • Contributors IM participated in conceptualization, methodology, investigation, data curation, writing the original draft, reviewing and editing, and visualization. EMM participated in software, formal analysis, investigation, data curation, and writing the original draft, reviewing and editing, and visualization. SN participated in reviewing and editing and visualization. WK, JC, and JF participated in reviewing and editing and visualization. DO'M participated in reviewing and editing and visualization. LMC participated in conceptualization, methodology, formal analysis, data curation, and reviewing, editing and project supervision. LMC is responsible for the overall content as guarantor.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.